Cardiovascular Systems to Present at Barclays 2015 Global Healthcare Conference

On Wednesday, March 11, 2015, Cardiovascular Systems’ (NASDAQ: CSII) President and Chief Executive Officer, David L. Martin, will present at the Barclays 2015 Global Healthcare Conference at 9:15 a.m. Eastern Time.

You may access the live audio webcast and presentation materials in the Investors section at:http://www.csi360.com. Presentation materials also will be archived on CSI’s website.

About Cardiovascular Systems, Inc.Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital Atherectomy System in peripheral arteries in August 2007. In October 2013, the company received FDA approval for the use of the Diamondback Orbital Atherectomy System in coronary arteries. To date, nearly 182,000 of CSI’s devices have been sold to leading institutions across the United States. For more information, visit the company’s website at www.csi360.com.

Cardiovascular Systems, Inc.Jack Nielsen, 651-202-4919j.nielsen@csi360.comorPadillaCRTMatt Sullivan, 612-455-1709matt.sullivan@padillacrt.com

Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From May 2024 to Jun 2024